1 / 18

Single Cell RNA Sequencing Market

The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound annual growth rate (CAGR) of 17.08% during the forecast period 2021-2031.<br>

bisreports
Download Presentation

Single Cell RNA Sequencing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Single Cell RNA Sequencing Market - A Global and Regional Analysis Table of Content GLOBAL SINGLE CELL RNA SEQUENCING MARKET https://www.shutterstock.com/image-illustration/messenger-rna-mrna-strand-3d-rendering-1907619631 Focus on Product, Workflow, End User and Application, Supply Chain, and Country- Wise Analysis Analysis and Forecast: 2021-2031 February 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. GLOBAL SINGLE CELL RNA SEQUENCING MARKET Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 17 1.Product Definition ...................................................................... 21 1.1 Inclusions and Exclusions .............................................................................. 21 2.Research Scope and Methodology ............................................. 22 2.1 Research Scope ............................................................................................... 22 2.2 Global Single Cell RNA Sequencing Market: Research Methodology ........ 23 2.3 Primary Data Sources ..................................................................................... 24 2.4 Secondary Data Sources ................................................................................ 25 2.5 Market Estimation Model ................................................................................. 26 Key Questions Answered in This Report ....................................................... 28 3.Markets ..................................................................................... 29 2.6 3.1 Market Overview .............................................................................................. 30 3.1.1Introduction of Single Cell RNA Sequencing ............................................ 30 3.1.2Current Applications of Single Cell RNA Sequencing ............................. 31 3.1.3Comparative Analysis of Single Cell RNA Sequencing Technology and Conventional RNA Sequencing Technology ..................................... 31 3.1.4Single Cell RNA Sequencing Market .......................................................... 32 3.2 Impact of COVID-19 on Global Single Cell RNA Sequencing Market .......... 33 3.3 COVID-19 Affecting Supply Chain of Single Cell RNA Sequencing Market ............................................................................................................... 34 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 3.4 Interruption in Research and Clinical Development and Commercial Operation .......................................................................................................... 35 3.4.1Research and Clinical Development .......................................................... 35 3.4.2Commercial Operation and Access ............................................................ 35 3.5 Navigating Crisis Recovery and Looking to the Future ............................... 35 3.6 Legal Requirements and Regulations ............................................................ 36 3.6.1Legal Requirements and Framework in the U.S. ...................................... 36 3.6.2Legal Requirements and Regulations in Europe ...................................... 39 3.6.3Legal Requirements and Framework in the Asia-Pacific ......................... 41 3 All rights reserved at BIS Research Inc.

  4. 3.6.3.1 China ................................................................................................................. 41 3.6.3.2 Japan ................................................................................................................. 41 4.Market Dynamics ....................................................................... 43 4.1 Market Drivers .................................................................................................. 43 4.1.1Rising Applications of Single Cell RNA Sequencing in Cancer Studies and Treatment ................................................................................ 43 4.1.2Increasing Diagnostics on a Global Level ................................................................... 46 Awareness and Acceptance of Personalized 4.1.3Decreasing Cost of Sequencing ................................................................. 47 4.1.4Increasing Government Funding for Healthcare ...................................... 48 4.2 Business Challenges ....................................................................................... 49 4.2.1Computational Challenges in Data Analysis of ScRNA Sequencing ...... 49 4.2.2High Capital Requirement ........................................................................... 49 4.2.3Lack of Infrastructure and Expertise ......................................................... 50 4.3 Business Opportunities .................................................................................. 50 4.3.1Expansion into Emerging Markets ............................................................. 50 4.3.2Expansion into New Research Application ............................................... 51 4.3.3Expansion of the Product Portfolio ........................................................... 51 5.Competitive Landscape ............................................................. 52 5.1 New Offerings .................................................................................................. 53 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 5.2 Mergers and Acquisitions ............................................................................... 53 5.3 Synergistic Activities ...................................................................................... 54 5.4 Business Expansion and Other Strategies .................................................... 55 Market Share Analysis, By Company ............................................................. 56 6.Global Single Cell RNA Sequencing Market (by Offering)............ 57 5.5 6.1 Global Single Cell RNA Sequencing Market (by Offerings) ), $ Million, 2020-2031.......................................................................................................... 58 6.1.1Consumables ............................................................................................... 59 6.1.2Instruments .................................................................................................. 59 7.Global Single Cell RNA Sequencing Market (by Workflow), $ Million, 2020-2031 ...................................................................... 61 4 All rights reserved at BIS Research Inc.

  5. 7.1 Single Cell Isolation ......................................................................................... 63 7.1.1Laser Capture Microscopy (LCM) .............................................................. 63 7.1.2Flow-Activated Cell Sorting (FACS) ........................................................... 64 7.1.3Magnetic-Activated Cell Sorting (MACS) ................................................... 65 7.1.4Microfluidics ................................................................................................ 66 7.2 Single Cell Amplification ................................................................................. 66 Library Preparation .......................................................................................... 67 8.Global Single Cell RNA Sequencing Market (by Application), $ Million, 2020-2031 ...................................................................... 69 7.3 8.1.1Oncology ...................................................................................................... 70 8.1.2Immunology ................................................................................................. 71 8.1.3Neurology ..................................................................................................... 72 8.1.4Embryology .................................................................................................. 74 8.1.5Others ........................................................................................................... 74 9.Global Single Cell RNA Sequencing (by End User), $Million, 2020 and 2031 ........................................................................... 76 9.1 Research Organizations .................................................................................. 77 9.2 Biopharmaceutical Companies ...................................................................... 78 Others ............................................................................................................... 79 10.Global Single Cell RNA Sequencing Market (by Region) , $ Million, 2020-2031 ...................................................................... 81 9.3 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 10.1North America .................................................................................................. 84 10.1.1U.S. ............................................................................................................... 85 10.1.2Canada ......................................................................................................... 86 10.2Europe .............................................................................................................. 89 10.2.1U.K. ............................................................................................................... 91 10.2.2Germany ....................................................................................................... 91 10.2.3Italy ............................................................................................................... 92 10.2.4Spain ............................................................................................................. 93 10.2.5France ........................................................................................................... 94 5 All rights reserved at BIS Research Inc.

  6. 10.2.6Rest-of-Europe............................................................................................. 95 10.3Asia-Pacific ...................................................................................................... 98 10.3.1Japan ............................................................................................................ 99 10.3.2China .......................................................................................................... 100 10.3.3India ............................................................................................................ 101 10.3.4South Korea ............................................................................................... 102 10.3.5Australia ..................................................................................................... 103 10.3.6Rest-of-Asia-Pacific ................................................................................... 104 10.4Rest-of-the-World .......................................................................................... 105 11.Company Profiles ..................................................................... 107 11.1Company Profiles .......................................................................................... 108 11.210x Genomics, Inc. ........................................................................................ 109 11.2.1Company Overview ................................................................................... 109 11.2.2Role of 10x Genomics, Inc. in Global Single Cell RNA Sequencing Market ......................................................................................................... 109 11.2.3Key Competitors of the Company ............................................................ 110 11.2.4Financials ................................................................................................... 111 11.2.5Key Insights About Financial Health of the Company ........................... 113 11.2.6SWOT Analysis .......................................................................................... 114 11.3BGI Group ....................................................................................................... 115 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 11.3.1Company Overview ................................................................................... 115 11.3.2Role of BGI Group in the Global Single Cell RNA Sequencing Market .................................................................................................................... 115 11.3.3Key Competitors of the Company ............................................................ 116 11.3.4SWOT Analysis .......................................................................................... 116 11.4Bio-Rad Laboratories, Inc. ............................................................................ 117 11.4.2Company Overview ................................................................................... 117 11.4.3Role of Bio-Rad Laboratories, Inc. in the Global Single Cell RNA Sequencing Market .................................................................................... 117 11.4.4Key Competitors of the Company ............................................................ 118 6 All rights reserved at BIS Research Inc.

  7. 11.4.5Financials ................................................................................................... 119 11.4.6Key Insights About Financial Health of the Company ........................... 121 11.4.7SWOT Analysis .......................................................................................... 122 11.5Becton, Dickinson and Company (BD) ........................................................ 123 11.5.1Company Overview ................................................................................... 123 11.5.2Role of Becton, Dickinson and Company (BD) in the Global Single Cell RNA Sequencing Market ................................................................... 123 11.5.3Key Competitors of the Company ............................................................ 124 11.5.4Financials ................................................................................................... 125 11.5.5Key Insights About Financial Health of the Company ........................... 127 11.5.6SWOT Analysis .......................................................................................... 128 11.6Fluidigm Corporation .................................................................................... 129 11.6.1Company Overview ................................................................................... 129 11.6.2Role of Fluidigm Corporation in the Global Single Cell RNA Sequencing Market .................................................................................... 129 11.6.3Key Competitors of the Company ............................................................ 130 11.6.4Key Insights About Financial Health of the Company ........................... 130 11.6.5SWOT Analysis .......................................................................................... 133 11.7MedGenome ................................................................................................... 134 11.7.1Company Overview ................................................................................... 134 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 11.7.2Role of MedGenome in the Global Single Cell RNA Sequencing Market ......................................................................................................... 134 11.7.3Key Competitors of the Company ............................................................ 135 11.7.4SWOT Analysis .......................................................................................... 136 11.8NanoString Technologies, Inc. ..................................................................... 137 11.8.1Company Overview ................................................................................... 137 11.8.2Role of NanoString Technologies, Inc. in the Global Single Cell RNA Sequencing Market .................................................................................... 137 11.8.3Key Competitors of the Company ............................................................ 138 11.8.4Key Insights About Financial Health of the Company ........................... 138 11.8.5SWOT Analysis .......................................................................................... 141 7 All rights reserved at BIS Research Inc.

  8. 11.9Pacific Biosciences of California, Inc. ......................................................... 142 11.9.1Company Overview ................................................................................... 142 11.9.2Role of Pacific Biosciences of California, Inc. in the Global Single Cell RNA Sequencing Market ................................................................... 142 11.9.3Key Competitors of the Company ............................................................ 143 11.9.4Financials ................................................................................................... 143 11.9.5Key Insights About Financial Health of the Company ........................... 145 11.9.6SWOT Analysis .......................................................................................... 146 11.10QIAGEN N.V. ................................................................................................... 147 11.10.1 Company Overview ............................................................................. 147 11.10.2 Role of QIAGEN N.V. in the Global Single Cell RNA Sequencing Market ......................................................................................................... 147 11.10.3 Key Competitors of the Company ..................................................... 148 11.10.4 Financials ............................................................................................ 148 11.10.5 Key Insights About Financial Health of the Company ..................... 151 11.10.6 SWOT Analysis .................................................................................... 152 11.11PerkinElmer Inc. ............................................................................................. 153 11.11.1 Company Overview ............................................................................. 153 11.11.2 Role of PerkinElmer Inc. in the Global Single Cell RNA Sequencing Market .................................................................................... 153 11.11.3 Key Competitors of the Company ..................................................... 154 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 11.11.4 Financials ............................................................................................ 155 11.11.5 Key Insights About Financial Health of the Company ..................... 157 11.11.6 SWOT Analysis .................................................................................... 158 11.12Takara Bio, Inc. .............................................................................................. 159 11.12.1 Company Overview ............................................................................. 159 11.12.2 Role of Takara Bio, Inc. in the Global Single Cell RNA Sequencing Market .................................................................................... 159 11.12.3 Key Competitors of the Company ..................................................... 159 11.12.4 Key Insights about Financial Health of Company ............................ 160 11.12.5 SWOT Analysis .................................................................................... 162 8 All rights reserved at BIS Research Inc.

  9. 11.13Thermo Fisher Scientific Inc. ........................................................................ 163 11.13.1 Company Overview ............................................................................. 163 11.13.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell RNA Sequencing Market ........................................................................... 163 11.13.3 Key Competitors of the Company ..................................................... 164 11.13.4 Financials ............................................................................................ 164 11.13.5 Key Insights About Financial Health of the Company ..................... 166 SWOT Analysis .................................................................................... 167 Emerging Companies ..................................................................... 168 11.13.6 11.14Biomage Ltd. .................................................................................................. 168 11.15Nucleome Informatics Pvt Ltd. ..................................................................... 168 11.16Scailyte ........................................................................................................... 169 11.17Analytical Biosciences Limited. ................................................................... 169 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 9 All rights reserved at BIS Research Inc.

  10. List of Figures Figure 1: Trends in Single Cell Studies, November 2019-May 2020 Figure 2: Global Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 3: Impact Analysis of Market Drivers and Market Challenges Figure 4: Share of Key Market Strategies and Developments, January 2017- January 2022 Figure 5: Global Single Cell RNA Sequencing Market (by Region), 2020 and 2031 Figure 6: Global Single Cell RNA Sequencing Market Segmentation Figure 7: Global Single Cell RNA Sequencing Market Research Methodology Figure 8: Primary Research Figure 9: Bottom-Up Approach (Segment-Wise Analysis) Figure 10: Development History of Single Cell Sequencing Figure 11: Global Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 12: Positive and Negative Impact of COVID-19 on Single Cell RNA Sequencing Market Figure 13: Measure to Navigate Crisis Recovery Figure 14: Global Single Cell RNA Sequencing Market Dynamics Figure 15: Rising Number of New Cancer Cases (Comparative Analysis of the Cases in 2018 and 2020) Figure 16: Applications of Single Cell RNA Sequencing in Analysis of Tumour Heterogeneity Figure 17: Issues Addressed by Single Cell RNA Sequencing in Oncogenomics Figure 18: Increasing Government Spending for Healthcare, 2017 Figure 19: Share of Key Market Strategies and Developments, January 2017- January 2022 Figure 20: Share of New Offerings (by Company), January 2017-January 2022 GLOBAL SINGLE CELL RNA SEQUENCING MARKET Figure 21: Share of Mergers and Acquisitions (by Company), January 2017-January 2022 Figure 22: Share of Synergistic Activities (by Company), January 2017-January 2022 Figure 23: Share of Business Expansion and Other Strategies (by Company), January 2017-January 2022 Figure 24: Market Share Analysis of Global Single Cell RNA Sequencing Market (by Company), 2020 and 2021 Figure 25: Global Single Cell RNA Sequencing (by Offerings), $Million, 2020 and 2031 Figure 26: Global Single Cell RNA Sequencing Consumables Market, $Million, 2020-2031 Figure 27: Global Single Cell RNA Sequencing Instruments Market, $Million, 2020-2031 Figure 28: Global Single Cell RNA Sequencing (by Workflow), $Million, 2020 and 2031 Figure 29: Global Single Cell RNA Sequencing Market (Single Cell Isolation), $ Million, 2020-2031 10 All rights reserved at BIS Research Inc.

  11. Figure 30: Global Single Cell RNA Sequencing Laser Capture Microscopy Market, $Million, 2020-2031 Figure 31: Global Single Cell RNA Sequencing Flow-Activated Cell Sorting Market, $ Million, 2020-2031 Figure 32: Global Single Cell RNA Sequencing Magnetic-Activated Cell Sorting Market, $Million, 2020- 2031 Figure 33: Global Single Cell RNA Sequencing Microfluidics Market, $Million, 2020-2031 Figure 34: Global Single Cell RNA Sequencing Market (Single Cell Amplification), $Million, 2020-2031 Figure 35: Global Single Cell RNA Sequencing Market (Library Preparation), $Million, 2020-2031 Figure 36: Global Single Cell RNA Sequencing (by Application), $Million, 2020 and 2031 Figure 37: Global Single Cell RNA Sequencing Market (Oncology), $Million, 2020-2031 Figure 38: Global Single Cell RNA Sequencing Market (Immunology), $Million, 2020-2031 Figure 39: Global Single Cell RNA Sequencing Market (Neurology), $Million, 2020-2031 Figure 40: Global Single Cell RNA Sequencing Market (Embryology), $Million, 2020-2031 Figure 41: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031 Figure 42: Global Single Cell RNA Sequencing (by End-User Type), $Million, 2020 and 2031 Figure 43: Global Single Cell RNA Sequencing Market (Research Organizations), $Million, 2020-2031 Figure 44: Global Single Cell RNA Sequencing Market (Biopharmaceutical Companies), $Million, 2020- 2031 Figure 45: Global Single Cell RNA Sequencing Market (Others), $Million, 2020-2031 Figure 46: Global Single Cell RNA Sequencing Market (by Region), $Million, 2020 and 2031 Figure 47: North America Global Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 48: North America: Market Dynamics Figure 49: U.S. Single Cell RNA Sequencing Market, $Million, 2020-2031 GLOBAL SINGLE CELL RNA SEQUENCING MARKET Figure 50: Canada Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 51: Europe Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 52: Europe: Market Dynamics Figure 53: U.K. Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 54: Germany Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 55: Italy Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 56: Spain Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 57: France Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 58: Rest-of-Europe Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 59: Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 60: Asia-Pacific: Market Dynamics 11 All rights reserved at BIS Research Inc.

  12. Figure 61: Japan Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 62: China Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 63: India Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 64: South Korea Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 65: Australia Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 66: Rest-of-Asia-Pacific Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 67: Rest-of-the-World Single Cell RNA Sequencing Market, $Million, 2020-2031 Figure 68: Share of Key Companies Profiled Figure 69: 10x Genomics, Inc.: Product Portfolio Figure 70: 10x Genomics, Inc.: Overall Financials, $Million, 2017-2019 Figure 71: 10x Genomics, Inc.: Revenue (by Business Segment), $Million, 2017-2019 Figure 72: 10x Genomics, Inc.: Revenue (by Region), $Million, 2017-2019 Figure 73: : 10x Genomics, Inc.: R&D Expenditure, $Million, 2017-2019 Figure 74: 10x Genomics, Inc.: SWOT Analysis Figure 75: BGI Group: Product Portfolio Figure 76: BGI Group: SWOT Analysis Figure 77: Bio-Rad Laboratories, Inc.: Product Portfolio Figure 78: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2018-2020 Figure 79: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), $Million, 2018-2020 Figure 80: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2018-2020 Figure 81: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2018-2020 Figure 82: Bio-Rad Laboratories, Inc.: SWOT Analysis GLOBAL SINGLE CELL RNA SEQUENCING MARKET Figure 83: Becton, Dickinson and Company (BD): Product Portfolio Figure 84: Becton, Dickinson and Company (BD): Overall Financials, $Million, 2018-2020 Figure 85: Becton, Dickinson and Company (BD): Revenue (by Segment), $Million, 2018-2020 Figure 86: Becton, Dickinson and Company (BD): Revenue (by Region), $Million, 2018-2020 Figure 87: Becton, Dickinson and Company (BD): R&D Expenditure, $Million, 2018-2020 Figure 88: Becton, Dickinson and Company: SWOT Analysis Figure 89: Fluidigm Corporation: Overall Financials, $Million, 2016-2018 Figure 90: Fluidigm Corporation: Revenue (by Business Segment), $Million, 2016-2018 Figure 91: Fluidigm Corporation: Revenue (by Region), $Million, 2016-2018 Figure 92: Fluidigm Corporation: R&D Expenditure, $Million, 2016-2018 Figure 93: Fluidigm Corporation: SWOT Analysis 12 All rights reserved at BIS Research Inc.

  13. Figure 94: MedGenome: Product Portfolio Figure 95: MedGenome: SWOT Analysis Figure 96: NanoString Technologies, Inc.: Overall Financials, $Million, 2016-2018 Figure 97: NanoString Technologies, Inc.: Revenue (by Business Segment), $Million, 2016-2018 Figure 98: NanoString Technologies, Inc.: Revenue (by Region), $Million, 2016-2018 Figure 99: NanoString Technologies, Inc.: R&D Expenditure, $Million, 2016-2018 Figure 100: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), $Million, 2016-2018 Figure 101: NanoString Technologies, Inc.: SWOT Analysis Figure 102: Pacific Biosciences of California, Inc.: Product Portfolio Figure 103: Pacific Biosciences of California, Inc.: Overall Financials, $Million, 2018-2020 Figure 104: Pacific Biosciences of California, Inc.: Revenue (by Segment), $Million, 2018-2020 Figure 105: Pacific Biosciences of California, Inc.: Revenue (by Region), $Million, 2018-2020 Figure 106: Pacific Biosciences of California, Inc.: R&D Expenditure, $Million, 2018-2020 Figure 107: Pacific Biosciences of California, Inc.: SWOT Analysis Figure 108: QIAGEN N.V.: Product Portfolio Figure 109: QIAGEN N.V.: Overall Financials, $Million, 2018-2020 Figure 110: QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020 Figure 111: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020 Figure 112: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020 Figure 113: QIAGEN N.V.: SWOT Analysis Figure 114: PerkinElmer Inc.: Product Portfolio Figure 115: PerkinElmer Inc.: Overall Financials, $Million, 2018-2020 GLOBAL SINGLE CELL RNA SEQUENCING MARKET Figure 116: PerkinElmer Inc.: Revenue (by Segment), $Million, 2018-2020 Figure 117: PerkinElmer Inc.: Revenue (by Region), $Million, 2018-2020 Figure 118: PerkinElmer Inc.: R&D Expenditure, $Million, 2018-2020 Figure 119: PerkinElmer Inc.: SWOT Analysis Figure 120: Takara Bio Inc.: Overall Financials, $Million, 2015-2017 Figure 121: Takara Bio, Inc.: Revenue (by Business Segment), $Million, 2015-2017 Figure 122: Takara Bio, Inc.: Revenue (by Region), $Million, 2017 Figure 123: Takara Bio, Inc.: R&D Expenditure, $Million, 2015-2017 Figure 124: Takara Bio Inc.: SWOT Analysis Figure 125: Thermo Fisher Scientific Inc.: Product Portfolio Figure 126: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020 13 All rights reserved at BIS Research Inc.

  14. Figure 127: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2018–2020 Figure 128: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018–2020 Figure 129: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020 Figure 130: Thermo Fisher Scientific Inc.: SWOT Analysis GLOBAL SINGLE CELL RNA SEQUENCING MARKET 14 All rights reserved at BIS Research Inc.

  15. List of Tables Table 1: Difference between Single Cell RNA Sequencing and RNA Sequencing Table 2: Classification of Directive Groups IVDs Table 3: Declining Cost of Genome GLOBAL SINGLE CELL RNA SEQUENCING MARKET 15 All rights reserved at BIS Research Inc.

  16. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have the vision to be a leading and preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More GLOBAL SINGLE CELL RNA SEQUENCING MARKET Know More 16 All rights reserved at BIS Research Inc.

  17. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 GLOBAL SINGLE CELL RNA SEQUENCING MARKET 17 All rights reserved at BIS Research Inc.

  18. GLOBAL SINGLE CELL RNA SEQUENCING MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 18 All rights reserved at BIS Research Inc.

More Related